[SRNE] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 71.74%
YoY- -1,726.10%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 15,594 17,400 11,461 18,385 13,076 12,062 13,511 10.00%
PBT -210,499 -91,702 -220,599 -38,946 -178,068 -119,773 -167,340 16.48%
Tax -1,814 -1,015 -1,050 1,463 -33,055 386 -641 99.69%
NP -223,692 -90,687 -219,549 -40,815 -144,417 -119,803 -166,615 21.63%
Tax Rate - - - - - - - -
Total Cost 239,286 108,087 231,010 59,200 157,493 131,865 180,126 20.78%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -1,434.47 -521.19 -1,915.62 -222.00 -1,104.44 -993.23 -1,233.18 10.57%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS 0.00 -0.20 -0.55 -0.12 -0.47 -0.40 -0.57 -
EPS Diluted 0.00 -0.20 -0.55 -0.12 -0.47 -0.40 -0.57 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.